SGP SpyGlass Pharma, Inc.

Fundamentals / CIK 0001778922 / USD

SpyGlass Pharma, Inc. reported $226.3M in total assets and a net loss of $70.49M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open SGP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$37.28MFY 2024 Net Income: -$29.16M2024FY 2025 Net Income: -$39.87M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Research & Development $29.18M $19.98M
Total Operating Expenses $41.45M $27.06M
Operating Income -$41.45M -$27.06M
EBITDA -$40.84M -$26.79M
Interest Income $3.11M $1.32M
Income Before Tax -$39.87M -$29.16M
Income Tax Expense $0 $0
Net Income -$39.87M -$29.16M
Basic EPS -$103.10 -$93.52
Diluted EPS -$103.10 -$93.52
Basic Shares Outstanding 386.7K 311.9K
Diluted Shares Outstanding 386.7K 311.9K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Research & Development $10.03M $10.94M $8.54M $7.71M $8.09M $7.33M $6.05M
Total Operating Expenses $26.25M $21.97M $15.41M $13.63M $11.10M $9.30M $7.42M
Operating Income -$26.25M -$21.97M -$15.41M -$13.63M -$11.10M -$9.30M -$7.42M
EBITDA -$25.96M -$21.63M -$15.09M -$13.41M -$10.96M -$9.16M -$7.30M
Interest Income $1.99M $2.10M $1.59M $1.07M $1.28M $622K $126K
Income Before Tax -$24.25M -$19.86M -$13.82M -$12.55M -$9.82M -$8.68M -$8.82M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income -$24.25M -$19.86M -$13.82M -$12.55M -$9.82M -$8.68M -$8.82M
Basic EPS -$0.73 -$0.59 -$0.69 -- -$4.53 -$3.81 -$3.96
Diluted EPS -$0.73 -$0.59 -$0.69 -- -$4.53 -$3.81 -$3.96
Basic Shares Outstanding 33.5M 33.4M 19.9M -- 2.2M 2.3M 2.2M
Diluted Shares Outstanding 33.5M 33.4M 19.9M -- 2.2M 2.3M 2.2M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $96.36M $16.27M
Cash & Short-Term Investments $96.36M $16.27M
Total Current Assets $108.8M $17.41M
Property, Plant & Equipment, Net $2.34M $2.17M
Other Non-Current Assets $492K $453K
Total Non-Current Assets $7.10M $5.91M
Total Assets $115.9M $23.32M
Accounts Payable $2.70M $1.98M
Other Current Liabilities $3.71M $672K
Total Current Liabilities $8.58M $7.79M
Total Non-Current Liabilities $1.58M $3.46M
Total Liabilities $10.17M $11.25M
Total Debt (incl. Leases) $1.57M $3.90M
Common Stock $0 $0
Retained Earnings -$104.7M -$64.86M
Total Stockholders' Equity -$98.84M -$60.47M
Total Equity -$98.84M -$60.47M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2024-12-31
Cash & Cash Equivalents $208.7M $223.1M $238.9M $96.36M $16.27M
Cash & Short-Term Investments $208.7M $223.1M $238.9M $96.36M $16.27M
Total Current Assets $217.9M $236.5M $253.4M $108.8M $17.41M
Property, Plant & Equipment, Net $6.34M $4.79M $2.75M $2.34M $2.17M
Other Non-Current Assets $689K $759K $789K $492K $453K
Total Non-Current Assets $8.43M $6.97M $5.02M $7.10M $5.91M
Total Assets $226.3M $243.4M $258.4M $115.9M $23.32M
Accounts Payable $5.65M $4.16M $3.51M $2.70M $1.98M
Other Current Liabilities $6.14M $3.56M $2.27M $3.71M $672K
Total Current Liabilities $14.30M $9.44M $6.67M $8.58M $7.79M
Total Non-Current Liabilities $1.61M $1.63M $1.61M $1.58M $3.46M
Total Liabilities $15.91M $11.07M $8.27M $10.17M $11.25M
Total Debt (incl. Leases) $1.61M $1.63M $1.61M $1.57M $3.90M
Common Stock $0 $0 $0 $0 $0
Retained Earnings -$162.7M -$138.4M -$118.5M -$104.7M -$64.86M
Total Stockholders' Equity $210.4M $232.4M $250.1M -$98.84M -$60.47M
Total Equity $210.4M $232.4M $250.1M -$98.84M -$60.47M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$39.87M -$29.16M
Depreciation & Amortization $612K $271K
Stock-Based Compensation $2.79M $1.49M
Change in Payables $549K $1.34M
Operating Cash Flow -$32.70M -$22.03M
Capital Expenditure -$789K -$1.99M
Free Cash Flow -$33.49M -$24.02M
Investing Cash Flow -$11.79M $22.26M
Share Repurchases -$1.45M $0
Financing Cash Flow $124.6M $185K
Net Change in Cash $80.09M $419K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$24.25M -$19.86M -$13.82M -$12.55M -$9.82M -$8.68M -$8.82M
Depreciation & Amortization $280K $341K $318K $217K $137K $135K $124K
Stock-Based Compensation $2.31M $2.08M $1.68M $922K $932K $587K $345K
Change in Payables $1.51M $764K $953K $1.02M -$1.29M $1.19M -$372K
Operating Cash Flow -$16.02M -$14.84M -$13.54M -$9.34M -$8.84M -$6.33M -$8.20M
Capital Expenditure -$2.46M -$1.93M -$676K -$421K -$152K -$52K -$164K
Free Cash Flow -$18.48M -$16.77M -$14.22M -$9.76M -$8.99M -$6.38M -$8.37M
Investing Cash Flow $1.54M -$933K -$1.67M $574K -$12.15M -$52K -$164K
Financing Cash Flow $27K $13K $157.8M -$888K -$236K $75.61M $50.10M
Net Change in Cash -$14.46M -$15.76M $142.5M -$9.65M -$21.23M $69.24M $41.73M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Assets (ROA) -34.4% -125.1%
Current Ratio 12.67x 2.23x
Quick Ratio 11.23x 2.09x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31
Return on Equity (ROE) -33.5% -24.1% -17.9% -- -- -- --
Return on Assets (ROA) -31.1% -23.0% -17.4% -34.4% -- -- --
Current Ratio 15.24x 25.06x 38.00x 12.67x -- -- --
Quick Ratio 14.60x 23.65x 35.83x 11.23x -- -- --
Debt to Equity 0.01x 0.01x 0.01x -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001778922) · from December 31, 2024 Data through September 30, 2026 · synced Nov 20, 2026, 05:29 UTC · Open in terminal